PROQR THERAPEUTICS NV
PRQRNASDAQ🏆 #3005 by market capEarnings Nov 5US Equity
$1.90▼ $0.02 (−1.30%)
Live1h▼ 0.3%
24h▼ 1.3%
7d▼ 4.1%
14d▲ 8.9%
30d▲ 11.8%
1y▼ 0.3%
🏦Market Cap
$252M
Small Cap
📈Revenue Growth (YoY)
-30.5%
Declining
📊Gross Margin
—
💵FCF Margin
123.9%
Strong
⚖️P/S Ratio
16.4x
Expensive
Otter Score
63
Fair
📊
Analyst Ratings
Price
$1.90
Total
12
Raised
1
Lowered
0
Avg PT
$3.00
H / L
$3 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
Evercore ISI Group | Reiterated | Outperform | 2026-06-29 |
Jones Trading | Reiterated | Buy | 2026-06-26 |
Chardan Capital | Reiterated | Buy | 2026-06-26 |
JMP Securities | Reiterated | Market Outperform | 2025-06-27 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-06-27 |
Oppenheimer | Reiterated | Outperform | 2025-05-13 |
HC Wainwright & Co. | Reiterated | Buy | 2025-03-14 |
Raymond James | Upgraded | Outperform → Strong Buy | 2024-10-29 |
Citigroup | Reiterated | Neutral | 2024-04-18 |
HC Wainwright& Co. | Reiterated | Buy | 2024-03-14 |
Citi | Reiterated | Buy | 2019-11-19 |
Leerink Swann | Reiterated | Outperform | 2017-09-26 |
One row per institution, most recent rating